# Experimental Vaccine for Plasmodium Falciparum Malaria

> **NCT00340431** · PHASE1 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)**

## Conditions studied

- Plasmodium Falciparum Malaria
- Vaccines

## Interventions

- **DRUG:** MSP1(42)-FVO & MSP1(42)-3D7

## Key facts

- **NCT ID:** NCT00340431
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-06-09
- **Primary completion:** —
- **Final completion:** 2008-02-06
- **Target enrollment:** 0 (—)
- **Last updated:** 2017-07-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00340431

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00340431, "Experimental Vaccine for Plasmodium Falciparum Malaria". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00340431. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*